Arrhythmias account for over 300,000 annual deaths in the United States, and approximately half of all deaths are associated with heart disease. Mechanisms underlying arrhythmia risk are complex; however, work in humans and animal models over the past 25 years has identified a host of molecular pathways linked with both arrhythmia substrates and triggers. This chapter will focus on select arrhythmia pathways solved by linking human clinical and genetic data with animal models.
Keywords: ACM; ANK2; Action potential; Ankyrin-B; Arrhythmogenic Cardiomyopathy; Brugada syndrome; CPVT; Calcium; Catecholaminergic polymorphic ventricular tachycardia; Channelopathies; ERS; Early repolarization syndrome; FKBP12.6; HERG; KCNE2; KCNJ2; KCNJ8; KCNQ1; LQTS; Long QT syndrome; RYR2; Reentry arrhythmias; Repolarization; Ryanodine receptor; SCN5A; SQTS; Short QT syndrome; Ventricular arrhythmias; atrial arrhythmias.
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.